This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
coronavirus: Archive
How to Invest for the Future Economy
by Tracey Ryniec
We've had the pandemic stock winners and the recovery winners, but what happens next?
SPYNegative Net Change MLHRPositive Net Change VOONegative Net Change CBREPositive Net Change QQQMNegative Net Change
coronavirus stock-performance
Why Novavax (NVAX) Stock Fell 19% on Friday
by Madeleine Johnson
Shares of the biotech firm plunged 19.6% in Friday trading after it delayed U.S. submission for its Covid-19 vaccine for the third time.
NVAXPositive Net Change
biotechs coronavirus vaccines
What's Next For Stocks: 10% Pullback or Rolling Correction?
by Daniel Laboe
The enormous amount of sideline cash is still being put to work, with every marginal dip being bought right back up
GSPositive Net Change VTVPositive Net Change VUGNegative Net Change
coronavirus etfs large-cap tech-stocks
5 Pandemic Earnings All-Stars to Watch
by Tracey Ryniec
These 5 companies haven't missed during the pandemic and have spectacular earnings charts.
AMDPositive Net Change MSFTNegative Net Change VNegative Net Change SBUXNegative Net Change ENPHNegative Net Change
coronavirus earnings
Bull of the Day: Exact Sciences (EXAS)
by Kevin Cook
EPS surprises abound as Cologuard and Precision Oncology grow sales 20% into next year
EXASPositive Net Change ADPTPositive Net Change NVTAPositive Net Change NTRANegative Net Change GHPositive Net Change
cancer coronavirus genetics genomics
Bear of the Day: Inovio Pharmaceuticals (INO)
by Madeleine Johnson
Is it too late to buy this coronavirus vaccine stock?
PFEPositive Net Change MRNAPositive Net Change INOPositive Net Change ACADPositive Net Change
coronavirus medical pharmaceuticals
Bear of the Day: Quidel (QDEL)
by Kevin Cook
Estimates get slashed another 30% since their Q1 report, driving yoy projections negative into 2022
QDELNegative Net Change
coronavirus medical
Bull Of The Day: Facebook (FB)
by Daniel Laboe
Facebook (FB), the world's most powerful social media platform, is a more attractive investment today than ever before
FBNo Net Change
advertising coronavirus earnings media tech-stocks
Bull of the Day: National Vision (EYE)
by Kevin Cook
As a nation, optical care needs are rising and re-opening trends are spurring a big catch-up on exams
EYEPositive Net Change
coronavirus medical
Bear of the Day: Clorox (CLX)
by Tracey Ryniec
Rising costs are a problem for this former pandemic winner.
CLXPositive Net Change
consumer-discretionary consumer-staples coronavirus